In vivo and in vitro antagonism of intestinal bacteria against Shigellaflexneri. II. The inhibitory mechanism.
about
The intestinal microbiota and susceptibility to infection in immunocompromised patientsColonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiotaReproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.Inhibition of Escherichia coli translocation from the gastrointestinal tract by normal cecal flora in gnotobiotic or antibiotic-decontaminated miceProfound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.Inhibition of translocation of viable Escherichia coli from the gastrointestinal tract of mice by bacterial antagonismEfficiency of various intestinal bacteria in assuming normal functions of enteric flora after association with germ-free mice.Influence of antibiotics or certain intestinal bacteria on orally administered Candida albicans in germ-free and conventional mice.Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challengesMicrobiota-mediated colonization resistance against intestinal pathogens.Changes in the mouse intestinal microflora during weaning: role of volatile fatty acids.Function of various intestinal bacteria in converting germfree mice to the normal state.Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiotaEffect of the normal microbial flora on the resistance of the small intestine to infection.Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidityAdoptive transfer of T lymphocytes to T-cell-depleted mice inhibits Escherichia coli translocation from the gastrointestinal tract.Microbiota-mediated inflammation and antimicrobial defense in the intestine.Eating for two: how metabolism establishes interspecies interactions in the gutThe interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection.Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes.Bacterial translocation from the gastrointestinal tracts of rats receiving thermal injuryHost-Derived Sialic Acids Are an Important Nutrient Source Required for Optimal Bacterial Fitness In VivoECOLOGICAL FACTORS INFLUENCING THE RELATIONSHIPS BETWEEN KLEBSIELLA AND SHIGELLA IN MIXED CULTURE.The human intestinal microflora.Antagonistic effects of Bacillus natto and Streptococcus faecalis on growth of Candida albicans.Imbalance of the normal microbial flora. The germ-free alimentary tract.Antagonism among the normal anaerobic bacteria of the mouse gastrointestinal tract determined by immunofluorescence.Microbiologic and clinical evidence supporting the role of Aeromonas caviae as a pediatric enteric pathogen.The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital in-patients and those taking antibiotics.Inhibition of Shigella flexneri by the normal intestinal flora. I. Mechanisms of inhibition by Klebsiella.EXPLANATION FOR LIMITATION OF POPULATIONS OF ESCHERICHIA COLI IN BROTH CULTURES.Role of competition for substrate in bacterial antagonism in the gut.Reduction of population levels of some indigenous bacteria by lactobacilli in the gastrointestinal tract of gnotobiotic rats.Distribution of indigenous bacteria in the digestive tract of conventional and gnotobiotic rats.[Influence of nutrition on resistance to infections].Faecal bacterial profile, nitrogen excretion and mineral absorption in healthy dogs fed supplemental oligofructose.New opportunities for managing acute and chronic lung infections.
P2860
Q26862848-F7E92A69-D010-45CA-A996-DE75B1F74FC3Q33223739-6A7D7ECA-18F4-4167-953A-167B61571DCEQ33420665-FB0C7D03-6781-447D-AC22-63BF90A3A9DBQ33728333-D358007F-9622-4505-A188-52030E5EF711Q33907947-ADA6B3F6-34B0-4BF2-8B06-859BE9FA24D0Q34050235-4964CC46-2747-4101-A053-2092EEAC1CE9Q34091316-0C87735B-63C6-4CC7-8BF9-A69A78D23E1DQ34160150-55C00638-452C-4DE0-B039-1127CC343626Q34179722-D8F3460F-8273-4E10-9FC5-DDBDE9CA84EDQ34297628-F1DEE4DD-FA15-419C-AECE-D3C85C769867Q34324937-877E2DEE-9764-441A-8CBD-1C51E2DECE74Q34466563-C01E5C23-980C-45DD-A867-316401C6FBFCQ34475676-54A65816-4821-4D4D-BC92-0CF5983A6BC9Q35069150-14FC2312-167F-4BED-90F0-F55BD9313F51Q35182770-B0C3A482-5AB8-422F-9FF2-B193DED3F457Q35356530-BFCAED12-E664-44AA-A1FE-5325757DC2F1Q35441656-22EF2B23-1DCA-4224-A296-03F9B2B72CD2Q35541605-E6D1547B-744E-4CA1-8E4C-F21A682E3B9EQ35576672-979ED726-5BE1-44C2-B2F4-C3683112AC6CQ35577842-4F631E0A-6AC5-4F36-9291-92833CA5F805Q36346442-6D5400BD-E67D-4EC3-AA84-345DD9115259Q37079543-D27B890A-D0C4-4E2D-BB5E-BAEA84D8A429Q37123061-4D66A212-91A5-47BF-B0AA-7F861F7EC6F1Q37405726-AF147714-4918-41D6-A62C-7C47EEE21217Q39464835-A264F40D-3984-4D77-A519-D6907F530B4CQ39712597-839DBD57-A4C5-4280-8F58-C27F48FA20B1Q40027593-7969819F-7AB2-48D0-9225-EED550CC032CQ40076023-7FAFA2A0-605D-4283-A47F-ED4885A7C730Q40201061-38CEC598-BDB2-41F6-9440-81A0B7AE1DB4Q40201421-64122CAB-7DB1-421B-91FD-F24A23053D3BQ40245800-6BA626A2-0EBD-4913-ABA3-FF61857B7A5AQ40255808-DAC3EE6B-56A9-4875-97C4-DE0BB1078CC2Q40599297-E19D14AE-2E3A-4977-86D8-823F1276B0ADQ40840714-081E5F73-59E7-48EE-AFB9-2752E01B94C8Q40880653-96CDA1D8-225B-428A-AD66-14BE2908649DQ43537418-E83340BD-CAF0-47D1-AF32-356BFC430D59Q44230125-67799B2F-5AE2-409B-AE3F-08B4D0583D25Q47734944-C0C07E2D-4270-4281-AA85-83AEB0638571
P2860
In vivo and in vitro antagonism of intestinal bacteria against Shigellaflexneri. II. The inhibitory mechanism.
description
1962 nî lūn-bûn
@nan
1962年の論文
@ja
1962年学术文章
@wuu
1962年学术文章
@zh
1962年学术文章
@zh-cn
1962年学术文章
@zh-hans
1962年学术文章
@zh-my
1962年学术文章
@zh-sg
1962年學術文章
@yue
1962年學術文章
@zh-hant
name
In vivo and in vitro antagonis ...... II. The inhibitory mechanism.
@en
In vivo and in vitro antagonis ...... II. The inhibitory mechanism.
@nl
type
label
In vivo and in vitro antagonis ...... II. The inhibitory mechanism.
@en
In vivo and in vitro antagonis ...... II. The inhibitory mechanism.
@nl
prefLabel
In vivo and in vitro antagonis ...... II. The inhibitory mechanism.
@en
In vivo and in vitro antagonis ...... II. The inhibitory mechanism.
@nl
P356
P1476
In vivo and in vitro antagonis ...... II. The inhibitory mechanism.
@en
P2093
P356
10.1093/INFDIS/110.1.38
P407
P577
1962-01-01T00:00:00Z